Intramedullary nailing for fibrous dysplasia of lower limbs
- Authors:
- Xiaoqi Zhang
- Xifu Shang
- Yaofei Wang
- Rui He
- Guoguang Shi
View Affiliations
Affiliations: Department of Orthopedic Surgery, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, Anhui 230001, P.R. China
- Published online on: June 11, 2012 https://doi.org/10.3892/ol.2012.752
-
Pages:
524-528
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Fibrous dysplasia (FD) of the bone is rare and self-limiting. However, lesion expansion may occur, causing pain, deformity and pathological fracture, in which case surgery is occasionally required. Indicators of FD have not been previously described, although there are several surgical procedures reported (curettage, curettage and graft, and internal fixation). In this study we discuss whether intramedullary nailing of these lesions could result in more favorable outcomes in correcting deformities, including the prevention of secondary fractures and maintenance of the bone, compared to other internal fixation methods. A total of 39 patients with FD of the bone treated with intramedullary nailing were retrospectively analyzed. The surgical procedures involved curettage, grafting and intramedullary nailing. No infection, thromboembolism or other notable complications occurred. The patients resumed full activities of daily living. At the last follow-up, 33 patients presented no pain and seven patients had occasional mild pain. The clinical score according to the modified criteria of Guille improved from an average of 4.4 points prior to surgery to an average of 8 points following surgery. The neck shaft angle of the femur improved from an average of 90˚ prior to surgery to 125˚ following surgery. Intramedullary nailing may be used to correct deformity and prevent pain and refracture in FD of the bone of the lower limbs with large lesions, pathological fracture or deformities. All patients were allowed full athletic recovery following surgery.
View References
|
1
|
Campanacci M: Bone and Soft Tissue Tumors:
Clinical Features, Imaging, Pathology, and Treatment. 2nd edition.
Springer; New York, NY: 1999, View Article : Google Scholar
|
|
2
|
Von Recklinghausen F: Die Fibrose oder
deformierende Ostitis, die Osteomalacie und die oesteoplastische
carcinose in ihren gegenseitigen Beziehungen. In: Festschrift
Rudolf Virchow zum 13; Oktober; Berlin. 1891, PubMed/NCBI
|
|
3
|
Lichtenstein L: Polyostotic fibrous
dysplasia. Arch Surg. 36:874–898. 1938. View Article : Google Scholar
|
|
4
|
Lichtenstein L and Jaffe HL: Fibrous
dysplasia of bone: a condition affecting one, several or many
bones, graver cases of which may persent abnormal pigmentation of
skin, premature sexual development, hyperthyroidism or still other
extraskeletal abnormalities. Arch Pathol. 33:777–816. 1942.
|
|
5
|
Wirth WA, Leavitt D and Enzinger FM:
Multiple intramuscular myxomas. Another extraskeletal manifestation
of fibrous dysplasia. Cancer. 27:1167–1173. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Blasier RD, Ryan JR and Schaldenbrand MF:
Multiple myxomata of soft tissue associated with polyostotic
fibrous dysplasia. A case report. Clin Orthop Relat Res.
206:211–214. 1986.PubMed/NCBI
|
|
7
|
Dorfman HD and Czerniak B: Bone Tumors.
Mosby; St. Louis, MO: 1998
|
|
8
|
Guille JT, Kumar SJ and MacEwen GD:
Fibrous dysplasia of the proximal part of the femur. Long-term
results of curettage and bone-grafting and mechanical realignment.
J Bone Joint Surg Am. 80:648–658. 1998.PubMed/NCBI
|
|
9
|
Kusano T, Hirabayashi S, Eguchi T and
Sugawara Y: Treatment strategies for fibrous dysplasia. J Craniofac
Surg. 20:768–770. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
DiCaprio MR and Enneking WF: Fibrous
dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint
Surg Am. 87:1848–1864. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Easley ME and Kneisl JS: Pathological
fractures through large nonossifying fibromas: is prophylactic
treatment warranted? J Pediatr Orthop. 17:808–813. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Arata MA, Peterson HA and Dahlin DC:
Pathological fractures through non-ossifying fibromas. Review of
the Mayo Clinic experience. J Bone Joint Surg Am. 63:980–988.
1981.PubMed/NCBI
|
|
13
|
Drennan DB, Maylahn DJ and Fahey JJ:
Fractures through large non-ossifying fibromas. Clin Orthop Relat
Res. 103:82–88. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ahn JI and Park JS: Pathological fractures
secondary to unicameral bone cysts. Int Orthop. 18:20–22.
1994.PubMed/NCBI
|
|
15
|
Betsy M, Kupersmith LM and Springfield DS:
Metaphyseal fibrous defects. J Am Acad Orthop Surg. 12:89–95.
2004.
|
|
16
|
O’Sullivan M and Zacharin M:
Intramedullary rodding and bisphosphonate treatment of polyostotic
fibrous dysplasia associated with the McCune-Albright syndrome. J
Pediatr Orthop. 22:255–260. 2002.PubMed/NCBI
|
|
17
|
Yanagawa T, Watanabe H, Shinozaki T and
Takagishi K: Curettage of benign bone tumors without grafts gives
sufficient bone strength. Acta Orthop. 80:9–13. 2009. View Article : Google Scholar : PubMed/NCBI
|
